Approximately 6 years of research and development of diagnostic kit for the prediction of prognosis of stomach cancer patients are completed and is currently undergoing the clinical test by the Ministry of Food and Drug Safety. Confirmative clinical test is planned after the completion of currently implemented exploratory clinical test with the schedule to formally launch the product to the market in 2017 after having undergone product licensing and new health technology assessment.
The accompanied diagnostic kit for lung cancer secured the cfDNA separation technology and very low frequency of somatic mutations (VELOW) analysis technology, and was selected as investment-linked task of the project for technology innovation and development by the Small and Medium Business Administration with the acknowledgement of the research and development performances and business feasibility. NGS System Set-up was completed in July 2016 and procedures for licensing by the Ministry of Food and Drug Safety are scheduled to commence.
- Use of nDx 1 Software is only available to partners who are registered separately in Novomics.
- You must pass the certification procedure on the next screen before you can use the software.
- Click the "Certification" button to install it automatically on your connection PC.
If you do not want to install, click the "Close Screen" button.
Please input partner number
[Contact Us] Subscription : 822-2068-3700
Partner number / forgot password : 822-2068-3700